Humate p dosing

Additionally, each vial of Humate-P also contains vWF:RCof activity in IU for the treatment of VWD. Recommended Dose and Dosage Adjustment. Therapy For

Humate-P has a higher Factor potency than cryoprecipitate preparations. Each vial of Humate-P contains the labeled amount of Factor VIII activity in international units. Additionally, each vial of Humate-P also contains the labeled amount of von Willebrand Factor:Ristocetin Cofactor (VWF:RCo) activity expressed in IU (see DOSAGE AND

This online Humate-P Dosage Calculator makes individual dosing fast, easy, and convenient for patients with von Willebrand disease (VWD).

Medication List – Available Products ; vWF Complex Concentrates. Alphanate; Humate-P Vonvendi; Wilate ; Plasma Derived Factor VIII. Alphanate; Koate; Humate-P

Mix2Vial . The Mix2Vial transfer device gives you a simple way to reconstitute HUMATE-P. For healthcare professionals and patients, the Mix2Vial is efficient and convenient, helping to minimize the risk of accidental injury and the time required to prepare HUMATE-P.

Humate-P) Us Study of Safety and Efficacy of Antihemophilic Factor / von Willebrand Factor Complex (Humate-P) Using Individualized Dosing in Pediatric

Access educational resources for Humate-P, including a video on hemostasis, a diagnosis tool for von Willebrand Disease, and a dosing guide.

What is HUMATE-P HUMATE-P is a VWF/FVIII replacement therapy that delivers results, patient after patient, treatment after treatment, decade after decade, as proven by a US study of the hemostatic efficacy of HUMATE-P. Based on this study, an independent Data Safety Monitoring Board judged hemostatic efficacy as effective in 94.3% of the perioperative study subjects.

P/Humate-P: Ristocetin Cofactor Unit Dosing in Patients with von Willebrand Disease